EUVIMEDEUVIMED entdecken
Crossref

Long noncoding RNA GHET1 promotes cell proliferation through oxidative stress in prostate cancer

Yongqin Wen, Huijie Huang, Bo Huang, Xiaomin Liao

Journal of Biochemical and Molecular Toxicology · 2023

DOI: 10.1002/jbt.23369 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2023. Verfasst von Yongqin Wen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Affiliated Dongguan Hospital, Southern Medical University, Dongguan, Guangdong, China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Prostatic Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastric carcinoma high expressed transcript 1 (GHET1) is an oncogenic Long noncoding RNA. GHET1 expression promotes multiple levels of developing a complex molecular network. The main purpose of the study was to investigate the mechanism by which long noncoding RNA (lncRNA) GHET1 promotes prostate cancer cell proliferation and related metabolism. In vitro study, lncRNA GHET1 was overexpressed in LN‐cap, PC‐3, 22RV1, and C4‐2 cells. The cell viability was measured by MTT and trans‐well assay. A flow cytometer was also used to detect cell cycles and apoptosis. Western blot analysis was used for protein expression validation. mRNA expression was detected by real‐time PCR. lncRNA GHET1 enhanced cell proliferation, migration, and could resist paclitaxel‐induced apoptosis and cell cycle arrest GHET1 expression stimulates reactive oxygen species (ROS) level upregulated in prostate cancer cells, increased the expression of HIFα, IL‐1B and IL‐6, and activated ROS/STAT‐3/Twsit1 signaling pathway. Knockdown GHET1 could reduce cell proliferation and migration due to the overexpression of GHET1. lncRNA GHET1 promotes prostate cancer growth through oxidative stress signaling pathways and resists the antineoplastic drug paclitaxel, which can be used as a target for antineoplastic therapy and drug resistance therapy in the future in clinics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingProstatic NeoplasmsMaleHumansCell Line, TumorReactive Oxygen SpeciesCell ProliferationOxidative StressCell MovementGene Expression Regulation, NeoplasticApoptosis

Stichwörter der Autor:innen

GHET1ROSproliferationprostate cancer

Substanzen

RNA, Long NoncodingReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Pathology, Affiliated Dongguan Hospital, Southern Medical University, Dongguan, Guangdong, China.

Zitieren

APA

Wen, Y., Huang, H., Huang, B., & Liao, X. (2023). Long noncoding RNA GHET1 promotes cell proliferation through oxidative stress in prostate cancer. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.23369

Vancouver

Wen Y, Huang H, Huang B, Liao X. Long noncoding RNA GHET1 promotes cell proliferation through oxidative stress in prostate cancer. Journal of Biochemical and Molecular Toxicology. 2023. doi:10.1002/jbt.23369

BibTeX
@article{Wen2023,
  author = {Wen, Yongqin and Huang, Huijie and Huang, Bo and Liao, Xiaomin},
  title = {Long noncoding RNA GHET1 promotes cell proliferation through oxidative stress in prostate cancer},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2023},
  doi = {10.1002/jbt.23369}
}
Kostenlos starten →